Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 23Gastric Adenocarcinoma 4Sarcopenia 2Adenocarcinoma 2Recurrence 1Peritoneal Neoplasms 1Patients Who Underwent Gastrectomy With Lymph Node Dissection for Gastric Cancer 1Osteoporosis 1Obesity, Abdominal 1Obesity 1Neoplasms 1Neoplasm Metastasis 1Motor Activity 1Margins of Excision 1Locally Advanced Gastric Carcinoma 1Locally Advanced Gastric Cancer 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Epstein-Barr Virus Infections 1Coitus 1Advanced Gastric Cancer 1

Interventions

Cyclophosphamide 115Dexamethasone 70fludarabine phosphate 57Cytarabine 56fludarabine 52Rituximab 51Peripheral Blood Stem Cell Transplantation 40Etoposide 40Gemcitabine 39Lenalidomide 38pembrolizumab 33Radiotherapy 33Busulfan 33Filgrastim 32Carboplatin 31Methotrexate 30Cyclosporine 29Cisplatin 29Bortezomib 29Mycophenolic Acid 28Melphalan 28venetoclax 27Paclitaxel 26Whole-Body Irradiation 24Antilymphocyte Serum 23Temozolomide 22Granulocyte Colony-Stimulating Factor 20Calcium Dobesilate 20Bevacizumab 20Tacrolimus 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Recurrence × Gastrectomy × Clear all
NCT02313688 2017-12-11

Length of the Proximal Resection Margin for Siewert-II/Siewert-III Tumors

West China Hospital

Phase NA Unknown
320 enrolled
Gastrointestinal

Margins of Excision, Recurrence, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡